AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program

Research and development expenses for the three months ended September 30, 2025 were approximately $607,000, compared to $1.4 million for the same period in 2024. General and administrative expenses ...

Data Center Coolant Distribution Units Research Report 2025-2032: Opportunities in Waste Heat Recovery Systems Integration, Nanofluids and Next-Generation Coolan…

The global data center coolant distribution units market is set to soar from USD 1.05 billion in 2025 to USD 7.74 billion by ...

The Walt Disney Company Reports Fourth Quarter and Full Year Earnings for Fiscal 2025

The Walt Disney Company (NYSE: DIS) today reported earnings for its fourth quarter and full year ended September 27, 2025.

Delhi Airport to get Terminal 4? DIAL’s 2026 Master Plan to decide fate of T2, T3

Delhi's Indira Gandhi International Airport is set to finalize its Master Plan 2026 by March. This plan will shape the ...
South Asia Monitor

CSR in South Asia: What It Means to the Corporate and Social World

An important pillar of CSR is the role of non-government organisations (NGOs) as partners in channeling funds to social ...